TAVR Innovations: What Have We Learned?
Once criticized by industry experts, transcatheter aortic valve replacement (TAVR) is now the standard of care for select patients at leading cardiac centers that specialize in the treatment of aortic stenosis. In this video, Dr. Allan Stewart, the Chief of Cardiac Surgery at Mercy Heart Institute in Miami, Florida, provides insights and research specific to the rapid adoption of non-invasive TAVR, new innovations that are enhancing TAVR patient outcomes, and the impact of patient-centric approaches for the treatment of aortic stenosis using TAVR. (Video posted on March 21, 2022)
Dr. Allan Stewart
Chief, Cardiac Surgery
Mercy Heart Institute